Short Interest in NextPlat Corp (NASDAQ:NXPL) Grows By 1,762.1%

NextPlat Corp (NASDAQ:NXPL) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 54,000 shares, an increase of 1,762.1% from the November 30th total of 2,900 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 119,400 shares, the days-to-cover ratio is currently 0.5 days.

NextPlat Stock Down 2.5 %

Shares of NASDAQ NXPL traded down $0.03 during trading hours on Friday, hitting $1.15. The stock had a trading volume of 124,780 shares, compared to its average volume of 277,401. The company has a market capitalization of $29.86 million, a P/E ratio of -1.69 and a beta of 0.85. The firm’s 50-day moving average price is $1.03 and its two-hundred day moving average price is $1.13. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. NextPlat has a 52 week low of $0.71 and a 52 week high of $2.68.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Omnia Family Wealth LLC bought a new position in shares of NextPlat Corp (NASDAQ:NXPL) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned about 0.49% of NextPlat at the end of the most recent reporting period. Institutional investors own 1.30% of the company’s stock.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.